FINWIRES · TerminalLIVE
FINWIRES

$HLN

6 stories mentioning HLNUpdated 10d ago

Every FINWIRES story that references HLN, newest first.

What are analysts saying about HLN?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on HLN?

Wire

Sector Update: Healthcare Stocks Edge Higher Late Afternoon

Healthcare stocks were slightly higher late Thursday afternoon, with the NYSE Healthcare Index increasing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1%.The iShares Biotechnology ETF (IBB) eased 0.3%.In corporate news, Haleon (HLN) has negotiated better shelf placement at Walmart (WMT) and Target (TGT), Reuters reported. The company reportedly said it has offered major retailers better prices and promotions, as well as exclusivity on new products, in exchange for more prominent shelf space. Haleon shares were down 1.1%.Hutchmed (HCM) shares jumped 17% after the company said its unit licensed rights to GSK (GSK) to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie (ABBV) said Thursday that it has completed its acquisition of Apogee Therapeutics (APGE), valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.5%.Ultragenyx Pharmaceutical (RARE) shares fell 44% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.Eli Lilly (LLY) unit Centessa Pharmaceuticals has achieved a late-stage development milestone related to its selective orexin receptor 2 agonist portfolio, triggering an $8.6 million payment to research collaboration partner Nxera Pharma, Nxera said Thursday. Lilly shares were down 0.2%.

$ABBV$HCM$HLN$LLY$RARE
Sectors

Sector Update: Healthcare

Healthcare stocks were slightly higher late Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1%.The iShares Biotechnology ETF (IBB) eased 0.3%.In corporate news, Haleon (HLN) has negotiated better shelf placement at Walmart (WMT) and Target (TGT), Reuters reported. The company said it has offered major retailers better prices and promotions, as well as exclusivity on new products, in exchange for more prominent shelf space. Haleon shares were down 1.2%.

$HLN
Wire

Market Chatter: Haleon Negotiates Better Shelf Placement at Walmart, Target

Haleon (HLN) has negotiated better shelf placement at Walmart (WMT) and Target (TGT), Reuters reported Thursday.Haleon was demerged from GlaxoSmithKline (GSK) in 2022.The company said it has offered major retailers better prices and promotions, as well as exclusivity on new products, in exchange for more prominent shelf space.Haleon, Target, and Walmart did not immediately respond to requests for comment from.Shares of Haleon were down 2%.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $9.76, Change: $-0.16, Percent Change: -1.61%

$GSK$HLN$TGT$WMT
Wire

Haleon Subsidiary Launches Cash Tender Offer for $2 Billion of Senior Notes

Haleon (HLN) subsidiary Haleon US Capital has launched a cash tender offer for all $2 billion of its outstanding 3.375% fixed-rate senior notes due March 2027, the company said Tuesday.The tender offer consideration will be determined using a fixed spread of 10 basis points over the 3.875% US Treasury due March 31, 2027, plus accrued and unpaid interest, the company said.The tender offer will expire at 5:00 p.m. ET on Aug. 18, unless extended or earlier terminated by the company, according to a statement.Haleon said the tender offer, together with a planned issuance of new bonds, is expected to help the company proactively manage and optimize its debt portfolio.Price: $9.94, Change: $-0.01, Percent Change: -0.10%

$HLN
Research

Rothschild & Co Redburn Downgrades Haleon to Neutral From Buy, Adjusts PT to $4.90 From $5.43

Haleon (HLN) has an average rating of overweight and mean price target of $11.20, according to analysts polled by FactSet.

$HLN
Asia Markets

US Equity Futures Higher Pre-Bell as Trump Tries to Keep Fragile Middle East Ceasefire Intact Amid New Israel-Iran Clashes

US equity futures were edging higher pre-bell Monday as President Donald Trump tried to hold together the fragile Middle East ceasefire after Israel and Iran exchanged attacks over the past few days.Dow Jones Industrial Average futures were 0.3% higher, S&P 500 futures were up 0.8%, and Nasdaq futures were 1.4% higher.In a post on Truth Social, Trump said that Israel and Iran were looking to do an "immediate" ceasefire after the two nations exchanged a series of attacks. Israeli forces on Sunday had launched strikes on Iran-backed Hezbollah forces inside Beirut, Lebanon, and Iran had retaliated with missile attacks. "The Blockade will remain in place, and in full force and effect, until a 'Final Deal' is reached," Trump said.The US imposed a blockade of Iranian ports after Iran barred transit of ships in the Strait of Hormuz.Oracle (ORCL) and Adobe (ADBE) are among the companies scheduled to release quarterly financial results within the week.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 1.8% at $94.74 per barrel and US West Texas Intermediate crude 1.4% higher at $91.82 per barrel.The NY Federal Reserve's June consumer inflation expectations index is scheduled to be released at 11 am ET.In other world markets, Japan's Nikkei closed 3.9% lower, Hong Kong's Hang Seng ended 1.2% lower, and China's Shanghai Composite finished 1.7% lower. Meanwhile, the UK's FTSE 100 was up 0.1%, and Germany's DAX index was 0.3% lower in Europe's early afternoon session.In equities, Nvidia (NVDA) shares rose 2.4% after a Bloomberg report cited company CEO Jensen Huang as saying that a global technology stock selloff was an opportunity to purchase shares at a discount. Eli Lilly (LLY) stock was up 1.7% after the drugmaker said its experimental obesity drug retatrutide delivered significant weight loss in two clinical studies and showed "meaningful" improvements in knee osteoarthritis pain and sleep apnea. Advanced Micro Devices (AMD) stock was up 3.7% after the company said it plans to invest up to 2 billion British Pounds ($2.7 billion) in the UK over the next five years to accelerate artificial intelligence research.On the losing side, Haleon (HLN) shares dropped 1% after the company said it plans to invest about 175 million pounds ($233.1 million) to build a new oral health manufacturing facility in Madhya Pradesh and expand distribution across rural India.

Dow JonesNasdaq CompositeS&P 500$ADBE$AMD$HLN$LLY$NVDA$ORCL

Track with the FINWIRES app suite

FolioX
FolioX
Track HLN in your portfolio
WheelAI
WheelAI
Analyze HLN options with the wheel strategy
StockInsider
StockInsider
See market sentiment on HLN